Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda Hemphill

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Current Treatment Options in Cardiovascular Medicine|May 17, 2017
Lipoprotein(a): A Lipoprotein Whose Time Has ComeErik Kelly, Linda Hemphill
Cardiology Clinics|May 6, 2015
Lipoprotein apheresisPatrick M Moriarty, Linda Hemphill
Endocrinology and Metabolism Clinics of North America|February 20, 2016
Lipoprotein ApheresisPatrick M Moriarty, Linda Hemphill
The Journal of Clinical Endocrinology and Metabolism|May 1, 2008
Growth hormone deficiency by growth hormone releasing hormone-arginine testing criteria predicts increased cardiovascular risk markers in normal young overweight and obese womenAndrea L Utz, Ami Yamamoto, Linda Hemphill, et al.
Journal of General Internal Medicine|January 18, 2020
Recognition and Treatment of Homozygous Familial Hypercholesterolemia by Primary Care Physicians: a Survey from the National Lipid AssociationLinda Hemphill, Anne Goldberg, Kees Hovingh, et al.
Journal of General Internal Medicine|October 28, 2020
Correction to: Recognition and Treatment of Homozygous Familial Hypercholesterolemia by Primary Care Physicians: a Survey from the National Lipid AssociationLinda Hemphill, Anne Goldberg, Kees Hovingh, et al.
Medical Research Archives|September 2, 2025
A Personalized Medicine Approach is Best for Patients with Homozygous Familial HypercholesterolemiaAna Morales, Allison Jamison, Robert A Hegele, et al.
Atherosclerosis|May 17, 2011
Associations of cardiovascular risk factors with two surrogate markers of subclinical atherosclerosis: endothelial function and carotid intima media thicknessKathleen V Fitch, Eleni Stavrou, Sara E Looby, et al.
AIDS (London, England)|August 10, 2012
Effects of aging and smoking on carotid intima-media thickness in HIV-infectionKathleen V Fitch, Sara E Looby, Alison Rope, et al.
AIDS (London, England)|November 25, 2011
Effects of lifestyle modification and metformin on atherosclerotic indices among HIV-infected patients with the metabolic syndromeKathleen Fitch, Suhny Abbara, Hang Lee, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Current Treatment Options in Cardiovascular Medicine|May 17, 2017
Lipoprotein(a): A Lipoprotein Whose Time Has ComeErik Kelly, Linda Hemphill
Cardiology Clinics|May 6, 2015
Lipoprotein apheresisPatrick M Moriarty, Linda Hemphill
Endocrinology and Metabolism Clinics of North America|February 20, 2016
Lipoprotein ApheresisPatrick M Moriarty, Linda Hemphill
The Journal of Clinical Endocrinology and Metabolism|May 1, 2008
Growth hormone deficiency by growth hormone releasing hormone-arginine testing criteria predicts increased cardiovascular risk markers in normal young overweight and obese womenAndrea L Utz, Ami Yamamoto, Linda Hemphill, et al.
Journal of General Internal Medicine|January 18, 2020
Recognition and Treatment of Homozygous Familial Hypercholesterolemia by Primary Care Physicians: a Survey from the National Lipid AssociationLinda Hemphill, Anne Goldberg, Kees Hovingh, et al.
Journal of General Internal Medicine|October 28, 2020
Correction to: Recognition and Treatment of Homozygous Familial Hypercholesterolemia by Primary Care Physicians: a Survey from the National Lipid AssociationLinda Hemphill, Anne Goldberg, Kees Hovingh, et al.
Medical Research Archives|September 2, 2025
A Personalized Medicine Approach is Best for Patients with Homozygous Familial HypercholesterolemiaAna Morales, Allison Jamison, Robert A Hegele, et al.
Atherosclerosis|May 17, 2011
Associations of cardiovascular risk factors with two surrogate markers of subclinical atherosclerosis: endothelial function and carotid intima media thicknessKathleen V Fitch, Eleni Stavrou, Sara E Looby, et al.
AIDS (London, England)|August 10, 2012
Effects of aging and smoking on carotid intima-media thickness in HIV-infectionKathleen V Fitch, Sara E Looby, Alison Rope, et al.
AIDS (London, England)|November 25, 2011
Effects of lifestyle modification and metformin on atherosclerotic indices among HIV-infected patients with the metabolic syndromeKathleen Fitch, Suhny Abbara, Hang Lee, et al.
Pageof 3